The official trailer for Tom Clancy`s Jack Ryan: Ghost War, starring John Krasinski in the lead, has been unveiled. After four successful seasons on Prime Video, this feature film finds our relatable hero Jack Ryan pulled back into the world of espionage for his most personal and dangerous mission yet. Set on a global stage, this intelligent thriller blends sharp storytelling with high-stakes action.
Jack Ryan Ghost War`s plot
In this new film, Jack Ryan is reluctantly thrust back into the world of espionage when an international covert mission unravels a deadly conspiracy, forcing him to confront a rogue black-ops unit, and the clock is ticking.
Operating in real time with lives on the line and the threat escalating at every turn, Jack reunites with battle-tested CIA operative Mike November (Michael Kelly) and former CIA boss James Greer (Wendell Pierce), their combined experience the only edge they have against an enemy who knows their every move. Backed by an unlikely new partner – razor-sharp MI6 officer Emma Marlowe (Sienna Miller) – Jack and the team navigate a treacherous web of betrayal, facing a past they thought was long put to rest – making this the most personal, high-stakes mission any of them has ever faced.
More about Jack Ryan Ghost War
John Krasinski, Wendell Pierce, and Michael Kelly round out this dynamic ensemble, whose characters and relationships made audiences fall in love with the series. Sienna Miller joins the cast as MI6 officer Emma Marlowe and proves every bit as sharp and savvy as Jack Ryan, forming an unstoppable duo.
The film is directed byAndrew Bernstein. The screenplay is written byAaron Rabin and John Krasinski, while the story is by Noah Oppenheim and John Krasinski. It is based on the characters created byTom Clancy.
Jack Ryan: Ghost War is produced by Allyson Seeger, p.g.a., John Krasinski, p.g.a., and Andrew Form. The executive Producers areJohn J. Kelly, Alexa Ginsburg, Carlton Cuse, and Tom Clancy.
The action drama has been rated R for “violence and language”and has a run-time of 105 Minutes.
It is going to premiere globally on Prime Video on May 20, 2026.
Ruling is latest loss for Trump administration, which has sought access to state voter data ahead of the US midterms.
Published On 17 Apr 202617 Apr 2026
A federal judge in the United States has dismissed a Department of Justice lawsuit seeking to access voter data from Rhode Island.
The decision on Friday was the latest loss for the administration of President Donald Trump, which has sought to access voter data in dozens of states across the country.
Recommended Stories
list of 3 itemsend of list
In the ruling, US District Court Judge Mary McElroy sided with election officials and civil rights groups, writing that the Justice Department does not have the authority “to conduct the kind of fishing expedition it seeks here”.
Rhode Island Secretary of State Gregg Amore praised the ruling in a statement afterwards.
“The executive branch seems to have no problem taking actions that are clear Constitutional overreaches, regularly meddling in responsibilities that are the rights of the states,” Amore wrote.
“But the power of our democratic republic, built on three, coequal branches of government, is clearer than ever before.”
The Justice Department has sued at least 30 states for their voter information, maintaining it needs the information to secure election security. State officials have said that turning over the data raises an array of privacy concerns.
Under the US Constitution, state officials administer elections. Only Congress can pass laws related to how states oversee voting.
But Trump has sought to transform election administration, claiming that voting has been marred by widespread fraud.
In particular, Trump has continued to maintain that the 2020 election, in which he lost to former President Joe Biden, was “stolen”.
No evidence has ever been put forward to support the claims.
Federal judges have rejected attempts in California, Massachusetts, Michigan and Oregon to force the states to hand over voter files to the federal government. At least 12 states, however, have willingly provided or pledged to provide voter information to the Trump administration.
The push for voter information is one of several actions that have raised concerns over how the Trump administration will approach the midterm elections in November, which will decide the makeup of the US Congress.
He is currently calling on Republicans to pass the so-called SAVE America Act, a bill that would create higher documentation standards for voters to prove their citizenship when registering to vote and casting ballots.
The majority of Republican lawmakers have embraced Trump’s claim that the law is needed to prevent non-citizens from registering to vote, despite studies showing that instances of voter fraud are glancingly rare.
Critics say the measure would risk disenfranchising millions of voters, particularly those who have legally changed their names, which is a common practice in US marriages.
Get set to groove on Senti, the season’s ultimate dance anthem! Neetu Kapoor, Kapil Sharma, Riddhima Kapoor, Sadia Khateeb and others tease you with the unmissable dance moves and tempt you to shake a leg. The makers recently announced the release date of Daadi Ki Shaadi, with the quirky title that caught everyone’s attention.
Senti song out
This electrifying song is composed by Payal Dev and Aditya Dev, with vocals by Payal Dev and Divya Kumar. Senti is the perfect song for every family gathering. The foot-tapping lyrics by Payal Dev, Aditya Dev, and Mohsin Shaikh will surely get you to the dance floor.
Kapil Sharma shared his thoughts on the song, saying,“For me, Senti is all about good vibes and togetherness. It’s the kind of song you’d want to play when you’re surrounded by family and friends, just enjoying the moment. Shooting it didn’t feel like work at all we were simply having fun on set. Working with Neetu ji, Riddhima, Sadia, Sharad Sir, and the entire cast was truly lovely. The stunning locations of Shimla added a special charm, it was like cherry on the cake. And I have to say, Payal Dev and Divya Kumar have brought so much life into the song, beautifully composed by Payal and Aditya Dev. The choreography by Ganesh Acharya is definitely a highlight for me.”
About Daadi Ki Shaadi
Daadi Ki Shaadi is a celebration of family, the quirks, the chaos, the secrets, and the unconditional love.
Revealing the release date on social media, the makers wrote, “Daadi is breaking the internet — and the rules! Is the family with her or against her? Find out in Daadi Ki Shaadi, releasing on 8th May. Gen D to Gen Z — all are invited (sic).”
Along with Neetu and Kapil as the lead, Daadi Ki Shaadi also marks the Bollywood debut of Neetu`s daughter and actor Ranbir Kapoor`s sister, Riddhima Kapoor Sahni. The ensemble cast features Sadia Khateeb, Tejaswini Kolhapure, R Sarath Kumar and others.
The makers also unveiled a feel-good poster from the movie, announcing the quirky title and release date, giving the audience a glimpse into this joyous, surprising, and irresistibly emotional family entertainer.
Produced by Rtake Studios, BeingU Studios and Shimla Talkies, the film is written and directed by Ashish R Mohan. The music is released via Warner Music India and is now available on all major streaming platforms.
Daadi Ki Shaadi arrives in cinemas on 8th May 2026.
The Indian Premier League returns to the M Chinnaswamy Stadium this Saturday for an afternoon clash that feels more like a homecoming than a routine fixture. All eyes will be on KL Rahul, the local favourite and Delhi Capitals’ batting mainstay, as he faces a Royal Challengers Bengaluru side that has looked formidable since winning their maiden title in 2025.
Nearly a month into IPL 2026, RCB have evolved into one of the most complete units in the competition. They will be keen to reinforce that reputation against a struggling Delhi Capitals outfit. Much of the spotlight has been on Virat Kohli, and the batting talisman has delivered, holding the Orange Cap. Yet, this RCB batting line-up no longer revolves solely around him.
RCB’s GREEN INITIATIVE
In a tradition dating back to 2011, Royal Challengers Bengaluru will don their green jerseys for this home fixture as part of their “Green Initiative.” The move symbolises the franchise’s commitment to environmental sustainability.
Made from recycled materials, the kits underline RCB’s status as a carbon-neutral T20 franchise, while also promoting accountability and encouraging fan participation in eco-friendly efforts.
THE ‘GREEN’ CURSE FOR VIRAT
While the green jersey remains a fan favourite, it has not always brought luck to Virat Kohli. The current Orange Cap holder in IPL 2026 with 228 runs has endured mixed returns when RCB steps away from their traditional colours.
Kohli’s most memorable outing in green came in 2016, when he smashed 109 off 55 balls against Gujarat Lions. However, despite solid contributions including a 62 in 2025 and a 73 in 2014, RCB have often found themselves on the losing side in this kit.
With Kohli in strong touch this season, including a recent 49 off 34 as an Impact Substitute, RCB will hope to finally put the so-called “green curse” behind them.
RAHUL’S FORTRESS: CHINNASWAMY
KL Rahul has consistently thrived at the Chinnaswamy Stadium, scoring 544 runs in 20 innings at an average of 41.84. His strike rate at the venue stands at 145.45, with the highest score of 93 not out.
His familiarity with the conditions could prove to be Delhi Capitals’ biggest weapon against the home side.
THE RCB JUGGERNAUT
Royal Challengers Bengaluru head into this clash in strong form, having dominated opponents through the 2026 campaign. Their only stumble came against Rajasthan Royals in Guwahati.
Captain Rajat Patidar, Devdutt Padikkal, Phil Salt and Tim David have all made decisive contributions with aggressive strokeplay, consistently stepping up in crucial moments. Patidar, in particular, has stood out with his remarkable six-hitting spree, topping the charts with 21 maximums from five matches, three more than Rajasthan Royals’ Vaibhav Sooryavanshi.
That collective firepower has allowed Kohli to bat with greater freedom, secure in the knowledge that the responsibility is shared across the line-up.
Barring that blip, Bengaluru have played fearless cricket and will look to dismiss Rahul early to prevent him from anchoring the innings.
DC SEARCH STABILITY
In contrast, Delhi Capitals are still searching for stability. Despite boasting experienced names such as KL Rahul, Pathum Nissanka, Tristan Stubbs, David Miller and Nitish Rana, consistency has eluded them. Even their fifth-place standing with four points feels misleading given their performances.
Young Sameer Rizvi has been the lone bright spot, scoring two half-centuries, but the broader batting struggles have been evident in consecutive defeats. Their two wins this season have come against Mumbai Indians and Kolkata Knight Riders, both of whom have endured difficult campaigns themselves.
Captain Axar Patel’s form has also been a concern. He has managed just three wickets and scored only three runs in four matches, reflecting a broader dip in all-round impact.
The inconsistency extends to their bowling. Kuldeep Yadav has struggled for rhythm, picking up just three wickets while conceding close to 10 runs per over. Pacers Mukesh Kumar and T Natarajan have also failed to deliver consistently.
RCB TEAM NEWS
The primary fitness concern for RCB is Virat Kohli, who picked up an ankle injury against Mumbai Indians. He featured as an Impact Substitute against Lucknow and may again be used primarily as a batter.
DC TEAM NEWS
Delhi Capitals will be without Mitchell Starc, who is yet to join the squad due to workload management by Cricket Australia. There is no clarity yet on his availability.
RCB VS DC: PITCH REPORT
The M Chinnaswamy Stadium is known for its batting-friendly surface, with matches often producing totals in excess of 200. The pitch offers consistent bounce and carry, favouring aggressive strokeplay.
Conditions are expected to be testing, with temperatures hovering between 35 to 36 degrees Celsius and humidity around 20 per cent.
RCB VS DC: PREDICTED PLAYING XIs
RCB: Phil Salt, Devdutt Padikkal, Rajat Patidar (c), Jitesh Sharma (wk), Tim David, Romario Shepherd, Krunal Pandya, Bhuvneshwar Kumar, Josh Hazlewood, Rasikh Dar, Suyash Sharma
Shaheen Bhatt flaunted a diamond ring to announce her engagement.
Shaheen Bhatt announces engagement
Shaheen Bhatt showed off her engagement ring while holding Ishaan close in the first picture. In another pic, she rested her head on Ishaan’s shoulder. In the caption, she wrote, “We may have overdone this whole liking each other thing.”
Alia Bhatt, Parineeti Chopra, Ananya Panday react to post
Alia shared the post of Shaheen on her Instagram Stories, and wrote, “Currently weeping (crying face emoticons).” Actor Parineeti Chopra commented on the post and wrote, “The Unbreakable Vow!” Filmmaker Zoya Akhtar wrote, “Congos and bongos.” Navya Nanda and Shanaya Kapoor also congratulated the couple. Meanwhile, Ananya Panday commented, “Shaheeeeen! Soooo happy for you (red heart emoticons) all the love and joy in the world.”
Exactly a year ago in April, Shaheen had made her relationship with fitness coach Ishaan Mehra Instagram official. She kept her chin on Ishaan’s shoulder as he clicked a selfie. The next photo showed Ishaan lying on the grass. Earlier last year, too, Shaheen had shared photos with Ishaan on Instagram but had not revealed his identity. The Kapoor and the Bhatt families took a trip to Thailand during the New Year. Taking to Instagram, Shaheen shared a bunch of pictures from the trip. In a photo, she posed next to Ishaan. They cuddled while on a cruise in another picture.
Shaheen was previously in a relationship with comedian Rohan Joshi. They parted ways a couple of years ago.
Shaheen Bhatt as a producer
Shaheen recently announced her new project, Don’t Be Shy! She and Alia will be co-producing the show under their banner, Eternal Sunshine Productions. The coming-of-age romantic comedy will introduce a cast drawn entirely from outside the film industry. Written and directed by Sreeti Mukerji, the film follows Shyamili “Shy” Das, a 20-year-old who believes her future is mapped out with precision. Her carefully structured life begins to unravel when an unexpected turn of events disrupts her plans, forcing her to confront uncertainty in matters of friendship, love and identity. Meanwhile, Alia will be seen next in Alpha.
Mumbai: Secondary deals are picking up pace as investors are looking at ways to exit their investments and get liquidity amid cooling of the IPO market on the back of war-driven volatility. “Globally, investment committees are postponing decisions, leading to funding delays. The secondaries market has picked up and we will see a lot more deals happening. In an uncertain environment, investors looking to offload stakes would be willing to sell them at a discount to get some liquidity,” said Gopal Jain, MD & CEO at Gaja Alternative Asset Management. In secondary transactions, shares change hands among investors and there is no primary fund infusion.Currently, about 10%-15% of IPO-bound companies are going for secondaries, said Rohit Mantri, MD & co-head, private equity at Motilal Oswal Alternates describing the deal momentum as “early signs” but if markets remain choppy, the volume of such deals will explode from the second half of the financial year, he said. Transactions are also taking time to close. “Investors are willing to sell at discount through secondary deals but they want the deals to close quickly. There are also not very large M&As happening right now,” said Siddarth Pai, founding partner at 3one4 Capital.
Companies which need acquisition financing or capex related requirements are accessing private markets again given IPOs have dried up while investors are banking on secondary deals for liquidity. What is helping secondary deals is the fact that private equity (PE) investors have rationalised their pricing expectations after correction in the stock prices of public listed companies, said Mantri. “About 50% of IPOs with market cap of over Rs 5,000 crore that happened last year are trading below their issue pricing now,” said Mantri, adding that the broader consensus is that IPO markets will rebound in H2.Extended hold periods and a growing pool of motivated sellers have been building for some time. In parallel, macro pressures stemming from the recent conflict are creating additional headwinds for traditional exit routes, increasing the need for alternative liquidity solutions, said Prabhav Kashyap, partner at Bain & Company. Secondary deals have been in favour since Covid times but what has changed now is that investors are setting up dedicated secondaries funds. PE firm TR Capital, for instance, last week said that it sees an opportunity to invest up to $1 billion in secondary transactions in India over five years. “What’s notable is that dedicated secondary capital is now scaling up its India presence in parallel, so you have supply and demand developing simultaneously in a meaningful way,” said Kashyap.
Pune: All three founders of ‘AeroDel Technology Innovations’ have experienced asthma firsthand. That gave them an edge when it came to designing respiratory devices, knowing wherein lay the gaps. So when their devices hit the market, they were an instant hit. Pharma giants lapped them up, with Zydus partnering with the startup.
AeroDel’s founders have one common denominator: asthma. This spurred them on to design respiratory devices that revolutionised the market. (HT)
Such enthusiastic responses spurred AeroDel on to innovate and broaden its horizon. Founded in 2020 by Zahir Jaffer, the company has progressed by leaps and bounds and achieved success within a short span of time, a rare feat for a startup. But, as Zahir would say, their success mantra lies in the simple fact that they “have lived the problem!”.
Living with asthma
“I had asthma in my childhood,” Zahir said. “Even though I outgrew it in my later years, I know it can be devastating when you get an attack.”
According to the World Health Organisation (WHO), India carries 12% of the global pool of 742 million asthma and Chronic Obstructive Pulmonary Disease (COPD) patients. In a single day, 3,300 people die from these respiratory diseases in the country.
Gaps in the market
“These may seem like numbers until you experience an attack yourself,” said Zahir, an MSc in Biotechnology Enterprise from Johns Hopkins University. He began his career with Glenmark in 2013, where he worked in product strategy for complex drug-device combination products before moving onto business development and alliance management. It was here that he was first exposed to the gaps in India’s respiratory device spaces.
Zahir left Glenmark in 2017 and co-founded ‘Blumen Biovitals’, a startup that licensed and sold nutraceutical finished products to large Indian pharmaceutical companies.
Shradha makes entry
In 2020, he recruited Shradha Sangwai to manage projects for the company. Shradha is a trained pharmacist, whose husband and son suffer from asthma.
Over time, Zahir realised that there was significant opportunity in respiratory device innovation. He felt that it would be far more interesting (and profitable) to own more of the value chain – to develop products themselves, not just license and sell.
“With respiratory diseases like asthma and COPD, we noticed that there was more potential in innovation on the devices used in treatment than on the molecules,” Zahir said. “So we thought, why not do something here?”
Problem with spacer
Their minds made up, Zahir and Shradha spoke to doctors and medical representatives across the country and received the same feedback.
“There were problems with the device itself,” Zahir said. “When a patient inhales via the pressurised metered-dose inhaler (pMDI), the drug is emitted very fast – faster than the speed at which it can be inhaled, which means not enough is going into the airways where it’s needed. Instead, it gets deposited in the mouth and throat, resulting in side effects like oral thrush and hoarse voice.”
Yet, despite these challenges, over 630 million pMDIs are manufactured globally every year. Doctors are
aware of the issue and recommend spacers (valved holding chambers) to improve pMDI drug delivery.
But, nine out of 10 times patients do not use spacers with their inhaler. Published research shows that
67-81% of patients knowingly stop using their spacers, and a survey of 715 patients confirmed that 87%
do not always use one. The reasons: spacers are too big to carry, patients do not like the way they look, do not feel like they do anything, and are embarrassed to use them outside the home.
“So you see, the problem does not end with the drug delivery,” Shradha said. “When your child needs a nebuliser in the dead of the night, you know what asthma can do. Patients with chronic mucus hypersecretion face additional challenges – frequent exacerbations, infections, and reduced quality of life, often with limited treatment options,”
And, beyond all of this, doctors have no way of knowing whether their patients are actually using inhalers correctly at home or not. “So despite pMDI and spacer being available for half a century, poor drug delivery and usability problems have not been solved,” Shradha said.
Simplifying inhalation
Zahir agreed with Shradha’s views and felt that the problem needed a solution. “And that is the problem our start-up, AeroDel, was founded to address: how do you simplify inhalation – drug delivery, airway clearance, nebulisation and disease management – for all respiratory patients?”
The two founders started off by focusing on patients’ needs, speaking to hundreds of them as well as medical representatives and doctors. Additionally, they started reading existing literature on the subject and conducted large-scale patient surveys. And when they felt they were ready, they began the actual work of creating devices that would be far more efficient and easy to use, following a patient-centred design process.
Flagship AeroFlex
“For our first product, AeroFlex, we developed a swivel mechanism – a ‘foldable always-attached’ concept – and got it patented in 2022,” Zahir said. “Laboratory testing showed that AeroFlex can deliver 50% of the drug to the lungs, while significantly reducing the drug deposited in the mouth and throat compared to using a pMDI that reaches 30% drug delivery.”
Suraj roped in
At this stage, they felt a strong need for a design expert to accelerate product development. And they approached Suraj Rajan, the third founder of the company.
K.K. Suraj Rajan is a mechanical engineering graduate from the University of Pune and had spent his career
building products across industries – orthopaedic implants at Johnson and Johnson in Mumbai and Leeds (UK), safety products at 3M, and medical devices at Biorad Medisys and Nesa Medtech. He had also co-founded Faberz Technologies, a product design consultancy.
Shradha and Zahir felt that Suraj was the perfect fit for AeroDel. They acquired Faberz and Suraj became the third co-founder in 2023.
The problem resonated immediately with Suraj too, just like it had with Shraddha and Zahir. Suraj’s wife has been living with asthma for years.
“When I saw what they were trying to do, it just clicked,” Suraj said. “I had spent my career designing products for medical use, but this was a chance to design something for my own family. The engineering challenge was clear: how to get spacer-level drug delivery into something small enough to stay in a patient’s pocket.”
So, from thereon, Suraj led the execution sprint – managing device design iterations, tooling, manufacturing infrastructure setup at the Pune facility, production, and assembly.
“Our iteration timelines were significantly shorter than what you’d typically see in medical devices,” Suraj said. “We had to move fast without compromising on quality – setting up manufacturing, qualifying tools, and producing commercial batches – all the while continuing to refine the design.”
AeroDel’s portfolio
Ever since the three came together, AeroDel has designed and developed a portfolio of devices for respiratory patients.
AeroFlex (pMDI enhancer) is their flagship product. A non-bulky spacer tube that remains attached to the patient’s pMDI and fits in your pocket. “Flip it open, inhale, fold it back. With AeroFlex, we wanted to evolve from spacers to a new category – pMDI enhancers,”
Suraj said.
Next in the line was AerOPEP, an airway clearance device that creates gentle vibrations when you exhale into it. These vibrations loosen mucus deep in the airways so that it can be coughed up. It replaces techniques that require a physiotherapist or hospital visit, and costs around ₹1,000. Clearing the airways can also improve inhaled drug delivery, Suraj explained.
And then there is JetMist, a portable nebuliser for geriatric patients and small children, that converts liquid medication into an inhalable mist. It is ultra-compact, runs on built-in batteries charged via USB-C, and can work anywhere. “It’s a far more convenient option than the large jet nebulisers that always need to be plugged into a socket, are bulky, and loud,” Shradha said.
And, last but not the least, comes ActiveControl, a small smart module that attaches to the pMDI and tracks whether the patient has taken medication or not, whether the inhalation technique was correct, and how the lung health is trending over time. “It sends the data to a mobile app, giving both the patient and doctor
visibility into what’s actually happening between clinic visits. Think of it as a fitness tracker for your inhaler,” said Zahir.
Sourcing funds
With all these devices in their basket, the founders’ hands are full. But, there was a time, especially during the research phase, when AeroDel was bootstrapped. The founders kept investing their time and resources while the early research and development (R&D) work was underway. Only when they had a patented product in hand, did they seek external help – funds to begin manufacturing and finding marketing partners.
The seed fund raised was ₹2.15 crore – from Venture Center, AIC-CCMB, and individual investors. MSInS provided support for international patent filing – up to ₹12 lakh. Government grants followed: ₹4 lakh from MeitY TIDE and ₹11 lakh from BFI-BIOME’s Kickstarter programme, both supported by C-CAMP. AeroDel also won $1,000 from Stanford’s Seed Spark Pitch.
In the second round, the founders’ target is ₹8 crore, to fund India launches of AerOPEP, JetMist, and SpiroDel Diagnostics; global launches of AeroFlex and AerOPEP in emerging markets and later the US and EU; and further R&D on ActiveControl and the broader pipeline of complex devices.
Tough competition
To set foot and leave a footprint in the respiratory device market is not at all easy as it is full of established players.
Zahir gave an insight into the market. Globally, Trudell Medical International’s AeroChamber has been the gold standard in spacers for decades, while Cipla’s Zerostat range dominates the Indian market. But all of these are conventional tube-shaped devices that patients carry separately, and as data shows, most patients simply don’t. In airway clearance, devices like Aerobika and Acapella are well-established internationally, but their pricing has kept them out of reach for most Indian patients.
Portable nebulisers from Omron, Philips, and others exist, but mesh-based designs are prone to clogging – a persistent frustration for patients and caregivers. And in the connected inhaler space, companies like Aptar and Adherium have developed smart add-ons for inhalers in Western markets, but no affordable option exists in India today.
AeroDel’s USP
However, no single competitor addresses all of these gaps. And this is AeroDel’s USP!
Suraj elaborated, “We’re building a portfolio that covers drug delivery, airway clearance, nebulisation, and monitoring – designed from the ground up for affordability and daily use in India, with global IP protection to take them international.”
AeroDel holds a granted utility patent in India, Australia, and Saudi Arabia, and has filed for patents in 46 other countries, including the US, 39 European countries, Brazil, Canada, among others. The company also has
four design registrations and has filed 13 trademarks.
Partnering with Zydus
But, they still felt the need to partner with an established company that has a wide reach across India – something that would take AeroDel years to build.
“We approached several pharma companies to partner with,” said Zahir, “And we chose Zydus given their vision for respiratory health and interest in innovation. With this partnership, Zydus leverages their expertise, strength, and distribution to bring the products into the hands of as many patients as possible. The complementary strengths pave the way for a successful partnership. It also allows AeroDel to focus on finding new problems and solving them for respiratory patients.”
Zydus has licensed two AeroDel products: Aerolife Mini™ (AeroFlex) and PEPAIR™ (AerOPEP), both now being launched pan-India.
Manufactured in Talawade
All AeroDel devices are manufactured at its facility in Talawade, Pune. The immediate focus is the pan-
India expansion of launched products with Zydus, followed by the launch of JetMist, SpiroDel
respiratory diagnostics, and ActiveControl.
Beyond the current portfolio, AeroDel’s ambitions extend to global markets and the development of increasingly complex devices such as next-generation dry powder inhalers, smart jet nebulisers, slow-mist inhalers, respiratory and sleep diagnostics, therapy solutions for obstructive sleep apnea, and ultra-compact oxygen concentrators.
Make in India
Although AeroDel started with the most urgent problems – getting more drugs to the lungs, clearing the airways, and making nebulisation portable, its founders’ vision has always been much broader.
They want AeroDel to be the company that simplifies every aspect of respiratory care for patients in India and, eventually, the world.
“We want to make devices in India for the whole world,” Zahir summed up.
Writer-director Karan Anshuman is returning to the streaming space with a new show. Glory, his latest title, merges both his favourite genres – sports and crime. But Glory is far removed from Inside Edge’s glitz as it is from Mirzapur’s rusticness. Set in Haryana, it follows two brothers – both former boxers – investigating a gruesome crime that has shaken their family, and may have ties to India’s Olympic hopes in boxing.
Glory, from Karan Anshuman, is a mystery centred around the world of boxing in Haryana.
Ahead of the show’s trailer launch in Mumbai, creator Karan Anshuman sat with Hindustan Times to discuss the world he built for Glory, its ‘genre mashup’, and why he wants the depiction of boxing in Indian entertainment to a new level with the show.
HT: How did the idea for Glory come about? How did this world originate?
KA: I’ve always been interested in sports. After Inside Edge, I just wanted to make a comeback to sports in some manner. But I also realised that it couldn’t be like a straightforward story. What you don’t want to make is another underdog story. We’ve seen enough of those in every biopic, and it’s the same template. So I thought we could do a genre mashup, for the lack of a better word. So, I merged something I am familiar with, with something that I haven’t done before, which is a mystery. That was a challenge I was really interested in taking up.
HT: And how did boxing come into the picture?
KA: I was enamoured of the culture of sports in Haryana and how much it means to its large population. Haryana is the one place that promotes sports so much. That felt like the perfect setting for Glory. So we went and explored these places like Rohtak and Bhiwani, and we were just blown away by how intense it is. What you see in the show is just a slight exaggeration of what’s going on there.
HT: Your shows have always been a heigthened reality zone where they feel real, but take liberties. Is that your voice?
KA: If you see my stuff, it’s always like it’s always taking something and then just elevating it. That is mainly so that we can create a world where we have our own rules, where certain things just go, and it has to be reality adjacent. That’s very important. So it’s relatable.
HT: The show is set in Shaktigarh, a fictional town in Haryana. What was the reasoning behind that, instead of setting it in a Bhiwani, for instance, which is actually India’s boxing capital.
KA: We are referring to Shaktigarh as Chhota Cuba, which we borrowed from Bhiwani. Then, we have put the Indian boxing headquarters over there, which is actually in Rohtak. So we have just mixed and matched a whole bunch of things and put them all in one. There’s also some real-life incidents, stories and anecdotal reports that we pulled from. That’s again something I really love leaning into. There’s also a sense that this is a town where these brothers come back after a long hiatus. So, it’s like the western trope of the cowboy returning.
HT: While the show is a mystery, boxing is central to it, particularly with so many bouts shown, and your actors playing boxers themselves. What were your thoughts when depicting the fights?
KA: What we were going for was to give the best boxing that we’ve seen on Indian entertainment in any manner. Hence, we had to get people who are invested in that idea. We involved a whole bunch of Indian boxers, who were involved in the training and also had little cameos. They were fun to work with. Pulkit (Samrat) had to train so much, and sometimes I felt like we spent more time dissecting his footwork and seeing how authentic that was as opposed to the amount of time we spent doing script reads, because for me, it was more important that you just give them the space and just see what comes out in the most natural manner.
Glory stars Pulkit Samrat, Divyenndu, and Suvinder Vicky. The series premieres on Netflix on May 1.
South Africa Women vs India Women Live Score, 1st T20I: The stage is set in Durban as South Africa women’s team chose to field after winning the toss against India women’s team in the series opener, renewing a rivalry that hasn’t seen a T20I contest since mid-2024.
India arrive as one of the in-form sides in women’s T20 cricket, having put behind their World Cup disappointment with a string of dominant bilateral performances. Series wins in challenging overseas conditions, including England and Australia, have reinforced their credentials as strong contenders heading into the next global tournament. The addition of young talents like Kashvee Gautam and Anushka Sharma adds depth, though the team’s backbone remains its experienced core.
For South Africa, the narrative is more about regaining rhythm. Finalists in the last two T20 World Cups, they are coming off a difficult New Zealand tour that exposed inconsistencies in both departments. The absence of seasoned campaigners like Dane van Niekerk and Marizanne Kapp further tests their balance.
With minimal changes to the squad, South Africa are banking on continuity and home conditions to spark a turnaround, while India will look to extend their dominant run and assert early control in the series.
